Merck & Co. is out of stock and dealing with back orders of some of its Sinemet Parkinson’s disease drug products that won’t be resolved until next year. The issues have resulted from manufacturing problems at the CMO that produces the
read moreMylan is battling claims that it illegally boosted EpiPen sales, and plaintiffs say the company is engaged in legal skullduggery in the process. They say the generics maker is secretly urging vendors to withhold certain subpoenaed documents. More: Mylan secretly
read moreMedherant has been awarded a grant by Innovate UK to help it upscale production of its TEPI Patch drug delivery system for clinical trials. More: Medherant awarded manufacturing grant from Innovate UK Source: News
read moreDraft guidelines from the National Institute for Health and Care Excellence do not recommend NHS funding for Takeda’s lung cancer drug Alunbrig. More: Preliminary NICE ‘no’ for Takeda’s Alunbrig Source: News
read moreUS regulators have approved Paratek’s Seysara for the treatment of acne in patients aged nine years or older. More: Green light for acne drug Seysara in the US Source: News
read moreEli Lilly’s CDK 4 and 6 inhibitor Verzenios has been approved in Europe for the treatment of certain metastatic breast cancers. More: EU nod for Lilly’s new breast cancer drug Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals